Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H28O5 |
Molecular Weight | 360.444 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]3([H])[C@@]2([H])CCC4=CC(=O)C=C[C@]34C
InChI
InChIKey=OIGNJSKKLXVSLS-VWUMJDOOSA-N
InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QS03CA02
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QS01CB02
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QA01AC54
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
NDF-RT |
N0000175576
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
S01CA02
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
D07CA03
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
C05AA04
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
S01CB02
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
A01AC54
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
S02CA01
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QC05AA04
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
CFR |
21 CFR 520.1880
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
NDF-RT |
N0000175450
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
CFR |
21 CFR 520.2604
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
03
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QD07XA02
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QH02AB56
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QS02BA03
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
CFR |
21 CFR 524.1484K
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
S01BB02
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
CFR |
21 CFR 520.2345H
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
CFR |
21 CFR 524.1484F
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
NCI_THESAURUS |
C521
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
A07EA01
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QD07CA03
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
EMA VETERINARY ASSESSMENT REPORTS |
EQUISOLON (AUTHORISED)
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
V03AB05
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QS01CA02
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
S03BA02
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
S01BA04
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QD07BA01
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
CFR |
21 CFR 524.1445
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
R01AD52
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
H02AB06
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QS03BA02
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QS01BA04
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
S02BA03
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
R01AD02
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
D07AA03
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
D07BA01
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QR01AD52
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
21.2
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QS02CA01
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.3
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QR01AD02
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QD07AA03
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
S03CA02
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QV03AB05
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QH02AB06
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
CFR |
21 CFR 520.2605
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-ATC |
D07XA02
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QA07EA01
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
LIVERTOX |
794
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
CFR |
21 CFR 522.1885
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
CFR |
21 CFR 524.1484J
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
||
|
WHO-VATC |
QS01BB02
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9900
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
2245
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
m9111
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | Merck Index | ||
|
PREDNISOLONE
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
5755
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
SUB10018MIG
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
PREDNISOLONE
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | Description: A white or almost white, crystalline powder; odourless. Solubility. Soluble in 1300 parts of water and in 30 parts of dehydrated ethanol R; soluble in methanol R and dioxan R. Category: Adrenocortical steroid. Storage: Prednisolone should be kept in a tightly closed container, protected from light. Additional information: Prednisolone is hygroscopic; it has a melting temperature of about 230?C with decomposition. Definition: Prednisolone contains not less than 97.0% and not more than 102.0% of C21H28O5, calculated with reference to thedried substance. | ||
|
8638
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | RxNorm | ||
|
9PHQ9Y1OLM
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
C769
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
1555005
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
DTXSID9021184
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
9PHQ9Y1OLM
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
3385
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
DB00860
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
535
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
100000091520
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
CHEMBL131
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
50-24-8
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
2866
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
D011239
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
8056-11-9
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
SUPERSEDED | |||
|
200-021-7
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
9120
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
Prednisolone
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY | |||
|
8378
Created by
admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
PRODRUG (METABOLITE ACTIVE)
PRODRUG (METABOLITE ACTIVE)
PRODRUG (METABOLITE ACTIVE)
SALT/SOLVATE (PARENT)